Articel Trio 5 mg/1,25 mg/5 mg filmom obložene tablete
| Name | Articel Trio 5 mg/1,25 mg/5 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-189997725 |
| Active Substance | perindoprilarginin indapamid amlodipinbesilat |
| Composition | jedna filmom obložena tableta sadrži 5 mg perindoprilarginina što odgovara 3,395 mg perindoprila, 1,25 mg indapamida i 5 mg amlodipina u obliku amlodipinbesilata. |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | Teva Operations Poland Sp. z o.o., Krakow, Poljska Actavis Limited, Zejtun, Malta |
| Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
| Marketing Authorisation Date | 23.08.2024 |
| MA Period of Validity | 23.08.2029 |
| Classification Number | UP/I-530-09/21-01/238 |
| Registration Number | 381-12-01/70-24-09 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C09BX01 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
